A detailed history of Nisa Investment Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 8,121 shares of FOLD stock, worth $86,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,121
Previous 7,842 3.56%
Holding current value
$86,082
Previous $92,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$9.04 - $11.75 $2,522 - $3,278
279 Added 3.56%
8,121 $80,000
Q1 2024

May 01, 2024

BUY
$11.43 - $14.24 $2,286 - $2,848
200 Added 2.62%
7,842 $92,000
Q4 2023

Jan 25, 2024

BUY
$9.97 - $14.52 $319 - $464
32 Added 0.42%
7,642 $108,000
Q2 2023

Aug 11, 2023

SELL
$10.72 - $13.3 $214 - $266
-20 Reduced 0.26%
7,610 $95,000
Q3 2022

Nov 07, 2022

BUY
$9.82 - $12.75 $1,865 - $2,422
190 Added 2.55%
7,630 $77,000
Q2 2022

Aug 03, 2022

SELL
$6.23 - $11.12 $7,102 - $12,676
-1,140 Reduced 13.29%
7,440 $80,000
Q1 2022

Apr 29, 2022

SELL
$7.89 - $12.48 $5,601 - $8,860
-710 Reduced 7.64%
8,580 $81,000
Q4 2021

Feb 03, 2022

SELL
$9.82 - $12.44 $14,140 - $17,913
-1,440 Reduced 13.42%
9,290 $87,000
Q2 2021

Aug 06, 2021

BUY
$8.71 - $10.72 $72,293 - $88,976
8,300 Added 341.56%
10,730 $103,000
Q1 2021

Apr 26, 2021

SELL
$9.2 - $23.86 $72,680 - $188,494
-7,900 Reduced 76.48%
2,430 $24,000
Q4 2020

Jan 25, 2021

BUY
$13.47 - $24.89 $18,858 - $34,846
1,400 Added 15.68%
10,330 $239,000
Q3 2020

Oct 20, 2020

BUY
$12.89 - $15.89 $88,941 - $109,641
6,900 Added 339.9%
8,930 $126,000
Q2 2020

Jul 27, 2020

BUY
$8.86 - $15.69 $1,860 - $3,294
210 Added 11.54%
2,030 $31,000
Q1 2020

Apr 17, 2020

SELL
$6.63 - $11.16 $9,613 - $16,182
-1,450 Reduced 44.34%
1,820 $17,000
Q4 2019

Jan 17, 2020

BUY
$7.48 - $10.75 $14,511 - $20,855
1,940 Added 145.86%
3,270 $32,000
Q3 2019

Oct 17, 2019

BUY
$8.02 - $13.25 $3,288 - $5,432
410 Added 44.57%
1,330 $11,000
Q3 2018

Oct 16, 2018

SELL
$11.6 - $16.54 $5,684 - $8,104
-490 Reduced 34.75%
920 $11,000
Q2 2018

Jul 19, 2018

BUY
$13.13 - $17.09 $2,757 - $3,588
210 Added 17.5%
1,410 $22,000
Q1 2018

Apr 10, 2018

SELL
$13.76 - $17.12 $6,329 - $7,875
-460 Reduced 27.71%
1,200 $18,000
Q3 2017

Oct 13, 2017

BUY
$11.74 - $15.78 $19,488 - $26,194
1,660
1,660 $25,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.97B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.